Report Detail

Pharma & Healthcare Global and China Perphenazine Drug Market Insights, Forecast to 2027

  • RnM4343654
  • |
  • 21 September, 2021
  • |
  • Global
  • |
  • Pages: NA
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Table of Contents

    1 Study Coverage

    • 1.1 Perphenazine Drug Product Introduction
    • 1.2 Market by Type
      • 1.2.1 Global Perphenazine Drug Market Size Growth Rate by Type
      • 1.2.2 Oral Forms
      • 1.2.3 Injectable Solution
    • 1.3 Market by Application
      • 1.3.1 Global Perphenazine Drug Market Size Growth Rate by Application
      • 1.3.2 Psychosis
      • 1.3.3 Antiemetic
    • 1.4 Study Objectives
    • 1.5 Years Considered

    2 Executive Summary

    • 2.1 Global Perphenazine Drug Market Size, Estimates and Forecasts
      • 2.1.1 Global Perphenazine Drug Revenue 2016-2027
      • 2.1.2 Global Perphenazine Drug Sales 2016-2027
    • 2.2 Global Perphenazine Drug, Market Size by Region: 2016 VS 2021 VS 2027
    • 2.3 Perphenazine Drug Historical Market Size by Region (2016-2021)
      • 2.3.1 Global Perphenazine Drug Retrospective Market Scenario in Sales by Region: 2016-2021
      • 2.3.2 Global Perphenazine Drug Retrospective Market Scenario in Revenue by Region: 2016-2021
    • 2.4 Perphenazine Drug Market Estimates and Projections by Region (2022-2027)
      • 2.4.1 Global Perphenazine Drug Sales Forecast by Region (2022-2027)
      • 2.4.2 Global Perphenazine Drug Revenue Forecast by Region (2022-2027)

    3 Global Perphenazine Drug Competitor Landscape by Players

    • 3.1 Global Top Perphenazine Drug Manufacturers by Sales
      • 3.1.1 Global Perphenazine Drug Sales by Manufacturer (2016-2021)
      • 3.1.2 Global Perphenazine Drug Sales Market Share by Manufacturer (2016-2021)
    • 3.2 Global Top Perphenazine Drug Manufacturers by Revenue
      • 3.2.1 Key Perphenazine Drug Manufacturers Covered: Ranking by Revenue
      • 3.2.2 Global Perphenazine Drug Revenue by Manufacturers (2016-2021)
      • 3.2.3 Global Perphenazine Drug Revenue Share by Manufacturers (2016-2021)
      • 3.2.4 Global Perphenazine Drug Market Concentration Ratio (CR5 and HHI) (2016-2021)
      • 3.2.5 Global Top 10 and Top 5 Companies by Perphenazine Drug Revenue in 2020
      • 3.2.6 Global Perphenazine Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 3.3 Global Perphenazine Drug Price by Manufacturers
    • 3.4 Global Perphenazine Drug Manufacturing Base Distribution, Product Types
      • 3.4.1 Perphenazine Drug Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Perphenazine Drug Product Type
      • 3.4.3 Date of International Manufacturers Enter into Perphenazine Drug Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type (2016-2027)

    • 4.1 Global Perphenazine Drug Market Size by Type (2016-2021)
      • 4.1.1 Global Perphenazine Drug Sales by Type (2016-2021)
      • 4.1.2 Global Perphenazine Drug Revenue by Type (2016-2021)
      • 4.1.3 Perphenazine Drug Average Selling Price (ASP) by Type (2016-2021)
    • 4.2 Global Perphenazine Drug Market Size Forecast by Type (2022-2027)
      • 4.2.1 Global Perphenazine Drug Sales Forecast by Type (2022-2027)
      • 4.2.2 Global Perphenazine Drug Revenue Forecast by Type (2022-2027)
      • 4.2.3 Perphenazine Drug Average Selling Price (ASP) Forecast by Type (2022-2027)

    5 Breakdown Data by Application (2016-2027)

    • 5.1 Global Perphenazine Drug Market Size by Application (2016-2021)
      • 5.1.1 Global Perphenazine Drug Sales by Application (2016-2021)
      • 5.1.2 Global Perphenazine Drug Revenue by Application (2016-2021)
      • 5.1.3 Perphenazine Drug Price by Application (2016-2021)
    • 5.2 Perphenazine Drug Market Size Forecast by Application (2022-2027)
      • 5.2.1 Global Perphenazine Drug Sales Forecast by Application (2022-2027)
      • 5.2.2 Global Perphenazine Drug Revenue Forecast by Application (2022-2027)
      • 5.2.3 Global Perphenazine Drug Price Forecast by Application (2022-2027)

    6 China by Players, Type and Application

    • 6.1 China Perphenazine Drug Market Size YoY Growth 2016-2027
      • 6.1.1 China Perphenazine Drug Sales YoY Growth 2016-2027
      • 6.1.2 China Perphenazine Drug Revenue YoY Growth 2016-2027
      • 6.1.3 China Perphenazine Drug Market Share in Global Market 2016-2027
    • 6.2 China Perphenazine Drug Market Size by Players (International and Local Players)
      • 6.2.1 China Top Perphenazine Drug Players by Sales (2016-2021)
      • 6.2.2 China Top Perphenazine Drug Players by Revenue (2016-2021)
    • 6.3 China Perphenazine Drug Historic Market Review by Type (2016-2021)
      • 6.3.1 China Perphenazine Drug Sales Market Share by Type (2016-2021)
      • 6.3.2 China Perphenazine Drug Revenue Market Share by Type (2016-2021)
      • 6.3.3 China Perphenazine Drug Price by Type (2016-2021)
    • 6.4 China Perphenazine Drug Market Estimates and Forecasts by Type (2022-2027)
      • 6.4.1 China Perphenazine Drug Sales Forecast by Type (2022-2027)
      • 6.4.2 China Perphenazine Drug Revenue Forecast by Type (2022-2027)
      • 6.4.3 China Perphenazine Drug Price Forecast by Type (2022-2027)
    • 6.5 China Perphenazine Drug Historic Market Review by Application (2016-2021)
      • 6.5.1 China Perphenazine Drug Sales Market Share by Application (2016-2021)
      • 6.5.2 China Perphenazine Drug Revenue Market Share by Application (2016-2021)
      • 6.5.3 China Perphenazine Drug Price by Application (2016-2021)
    • 6.6 China Perphenazine Drug Market Estimates and Forecasts by Application (2022-2027)
      • 6.6.1 China Perphenazine Drug Sales Forecast by Application (2022-2027)
      • 6.6.2 China Perphenazine Drug Revenue Forecast by Application (2022-2027)
      • 6.6.3 China Perphenazine Drug Price Forecast by Application (2022-2027)

    7 North America

    • 7.1 North America Perphenazine Drug Market Size YoY Growth 2016-2027
    • 7.2 North America Perphenazine Drug Market Facts & Figures by Country
      • 7.2.1 North America Perphenazine Drug Sales by Country (2016-2021)
      • 7.2.2 North America Perphenazine Drug Revenue by Country (2016-2021)
      • 7.2.3 United States
      • 7.2.4 Canada

    8 Asia Pacific

    • 8.1 Asia Pacific Perphenazine Drug Market Size YoY Growth 2016-2027
    • 8.2 Asia Pacific Perphenazine Drug Market Facts & Figures by Region
      • 8.2.1 Asia Pacific Perphenazine Drug Sales by Region (2016-2021)
      • 8.2.2 Asia Pacific Perphenazine Drug Revenue by Region (2016-2021)
      • 8.2.3 China
      • 8.2.4 Japan
      • 8.2.5 South Korea
      • 8.2.6 India
      • 8.2.7 Australia
      • 8.2.8 Australia
      • 8.2.9 Indonesia
      • 8.2.10 Thailand
      • 8.2.11 Malaysia

    9 Europe

    • 9.1 Europe Perphenazine Drug Market Size YoY Growth 2016-2027
    • 9.2 Europe Perphenazine Drug Market Facts & Figures by Country
      • 9.2.1 Europe Perphenazine Drug Sales by Country (2016-2021)
      • 9.2.2 Europe Perphenazine Drug Revenue by Country (2016-2021)
      • 9.2.3 Germany
      • 9.2.4 France
      • 9.2.5 U.K.
      • 9.2.6 Italy

    10 Latin America

    • 10.1 Latin America Perphenazine Drug Market Size YoY Growth 2016-2027
    • 10.2 Latin America Perphenazine Drug Market Facts & Figures by Country
      • 10.2.1 Latin America Perphenazine Drug Sales by Country (2016-2021)
      • 10.2.2 Latin America Perphenazine Drug Revenue by Country (2016-2021)
      • 10.2.3 Mexico
      • 10.2.4 Brazil
      • 10.2.5 Argentina

    11 Middle East and Africa

    • 11.1 Middle East and Africa Perphenazine Drug Market Size YoY Growth 2016-2027
    • 11.2 Middle East and Africa Perphenazine Drug Market Facts & Figures by Country
      • 11.2.1 Middle East and Africa Perphenazine Drug Sales by Country (2016-2021)
      • 11.2.2 Middle East and Africa Perphenazine Drug Revenue by Country (2016-2021)
      • 11.2.3 Turkey
      • 11.2.4 Saudi Arabia
      • 11.2.5 UAE

    12 Company Profiles

    • 12.1 Teva
      • 12.1.1 Teva Corporation Information
      • 12.1.2 Teva Description and Business Overview
      • 12.1.3 Teva Perphenazine Drug Sales, Revenue and Gross Margin (2016-2021)
      • 12.1.4 Teva Perphenazine Drug Products Offered
      • 12.1.5 Teva Recent Development
    • 12.2 Sandoz
      • 12.2.1 Sandoz Corporation Information
      • 12.2.2 Sandoz Description and Business Overview
      • 12.2.3 Sandoz Perphenazine Drug Sales, Revenue and Gross Margin (2016-2021)
      • 12.2.4 Sandoz Perphenazine Drug Products Offered
      • 12.2.5 Sandoz Recent Development
    • 12.3 Endo
      • 12.3.1 Endo Corporation Information
      • 12.3.2 Endo Description and Business Overview
      • 12.3.3 Endo Perphenazine Drug Sales, Revenue and Gross Margin (2016-2021)
      • 12.3.4 Endo Perphenazine Drug Products Offered
      • 12.3.5 Endo Recent Development
    • 12.4 Mylan
      • 12.4.1 Mylan Corporation Information
      • 12.4.2 Mylan Description and Business Overview
      • 12.4.3 Mylan Perphenazine Drug Sales, Revenue and Gross Margin (2016-2021)
      • 12.4.4 Mylan Perphenazine Drug Products Offered
      • 12.4.5 Mylan Recent Development
    • 12.5 ZHPHARMA
      • 12.5.1 ZHPHARMA Corporation Information
      • 12.5.2 ZHPHARMA Description and Business Overview
      • 12.5.3 ZHPHARMA Perphenazine Drug Sales, Revenue and Gross Margin (2016-2021)
      • 12.5.4 ZHPHARMA Perphenazine Drug Products Offered
      • 12.5.5 ZHPHARMA Recent Development
    • 12.6 Shandong Boshan Pharma
      • 12.6.1 Shandong Boshan Pharma Corporation Information
      • 12.6.2 Shandong Boshan Pharma Description and Business Overview
      • 12.6.3 Shandong Boshan Pharma Perphenazine Drug Sales, Revenue and Gross Margin (2016-2021)
      • 12.6.4 Shandong Boshan Pharma Perphenazine Drug Products Offered
      • 12.6.5 Shandong Boshan Pharma Recent Development
    • 12.11 Teva
      • 12.11.1 Teva Corporation Information
      • 12.11.2 Teva Description and Business Overview
      • 12.11.3 Teva Perphenazine Drug Sales, Revenue and Gross Margin (2016-2021)
      • 12.11.4 Teva Perphenazine Drug Products Offered
      • 12.11.5 Teva Recent Development

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Perphenazine Drug Industry Trends
    • 13.2 Perphenazine Drug Market Drivers
    • 13.3 Perphenazine Drug Market Challenges
    • 13.4 Perphenazine Drug Market Restraints

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Perphenazine Drug Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Perphenazine is a typical antipsychotic drug. Chemically, it is classified as a piperazinyl phenothiazine. Originally marketed in the US as Trilafon, it has been in clinical use for decades. Perphenazine is roughly five times as potent as chlorpromazine, thus perphenazine is considered a medium-potency antipsychotic

      Market Analysis and Insights: Global and China Perphenazine Drug Market
      This report focuses on global and China Perphenazine Drug market.
      In 2020, the global Perphenazine Drug market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. In China the Perphenazine Drug market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

      Global Perphenazine Drug Scope and Market Size
      Perphenazine Drug market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Perphenazine Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
      For China market, this report focuses on the Perphenazine Drug market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

      Segment by Type
      Oral Forms
      Injectable Solution

      Segment by Application
      Psychosis
      Antiemetic

      By Region
      North America
      United States
      Canada
      Europe
      Germany
      France
      U.K.
      Italy
      Russia
      Asia-Pacific
      China
      Japan
      South Korea
      India
      Australia
      China Taiwan
      Indonesia
      Thailand
      Malaysia
      Latin America
      Mexico
      Brazil
      Argentina
      Middle East & Africa
      Turkey
      Saudi Arabia
      UAE

      By Company
      Teva
      Sandoz
      Endo
      Mylan
      ZHPHARMA
      Shandong Boshan Pharma


      Summary:
      Get latest Market Research Reports on Perphenazine Drug. Industry analysis & Market Report on Perphenazine Drug is a syndicated market report, published as Global and China Perphenazine Drug Market Insights, Forecast to 2027. It is complete Research Study and Industry Analysis of Perphenazine Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,500.00
      $7,000.00
      2,548.00
      5,096.00
      3,013.50
      6,027.00
      399,840.00
      799,680.00
      262,605.00
      525,210.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report